In addition, DNER acts as a ligand for Notch1, activating the Notch signalling pathway11,15, and the knockdown of Notch1 expression can inhibit the migration and invasion of nasopharyngeal carcinoma cells by reversing EMT32. This evidence concerns the gene NOTCH1 and nasopharyngeal carcinoma.